Daily habits: Food choices, activity level, and sticking to the prescribed plan directly affect results
POP is a condition with a worldwide prevalence of 9% 126 , in which a womans pelvic muscles and tissues weaken, resulting in bulging of the pelvic organs (uterus, bladder, rectum) into the vagina 127
Lillys imlunestrant is expecting an FDA approval in late 2025/early 2026, while AstraZenecas approval for camizestrant will likely come in H1 2026
Not legally available over the counter as dietary supplements
For people with limited sunlight exposure or certain medical conditions, higher doses may be necessary
Procedure Description Preparation: Patients consult with ProCare Wellness Institute to assess suitability for the treatment